InvestorsHub Logo
Followers 62
Posts 7557
Boards Moderated 1
Alias Born 01/02/2003

Re: JRoon71 post# 388895

Friday, 09/16/2022 2:20:33 PM

Friday, September 16, 2022 2:20:33 PM

Post# of 426487
Amarin's primary market for Vascepa is for CVD reduction...The market for other conditions can wait...IMO Amarin should develop the statin-MD-2119 combo market even before developing the V2 market, thus keeping the Vascepa market they already have...while waiting for the combo market to develop
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News